Skip to main content
Navin Kapur, MD, Cardiology, Baltimore, MD

NavinKumarKapurMD

Cardiology Baltimore, MD

Adult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology

Physician

Are you Dr. Kapur?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-5000

Summary

  • Dr. Navin Kapur, MD is a cardiologist in Baltimore, Maryland. He is currently licensed to practice medicine in Virginia and Massachusetts.

Education & Training

  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2025
  • VA State Medical License
    VA State Medical License 2002 - 2008
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Interventional Cardiology
    American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Experts Hash Out Recommendations for Impella CP After DanGer Shock
    Experts Hash Out Recommendations for Impella CP After DanGer ShockFebruary 14th, 2025
  • Clinical Outcomes of the Post-Closure Technique for Arteriotomy Closure with the Impella Cardiac Power Percutaneous Left Ventricular Assist Device
    Clinical Outcomes of the Post-Closure Technique for Arteriotomy Closure with the Impella Cardiac Power Percutaneous Left Ventricular Assist DeviceAugust 26th, 2024
  • RECOVER IV Impella Trial Halted in the Wake of DanGer Shock
    RECOVER IV Impella Trial Halted in the Wake of DanGer ShockJune 18th, 2024
  • Join now to see all

Grant Support

  • New Approaches to Mitigate Left Ventricular Injury with VA-ECMO in Acute Myocardial InfarctionTUFTS MEDICAL CENTER2021–2025